Molecular Markers of Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus SCCmec IV Presenting Different Genetic Backgrounds

Methicillin-resistant Staphylococcus aureus (MRSA) carrying SCC mec type IV has emerged in hospitals worldwide. The aim of this study was to evaluate phenotypic and molecular characteristics of antimicrobial resistance in MRSA SCC mec IV isolates, presenting different genetic backgrounds, isolated f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Microbial drug resistance (Larchmont, N.Y.) N.Y.), 2016-12, Vol.22 (8), p.7-706
Hauptverfasser: de Matos, Pricilla Dias Moura, de Oliveira, Tamara Lopes Rocha, Cavalcante, Fernanda Sampaio, Ferreira, Dennis Carvalho, Iorio, Natália Lopes Pontes, Pereira, Eliezer Menezes, Chamon, Raiane Cardoso, dos Santos, Kátia Regina Netto
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methicillin-resistant Staphylococcus aureus (MRSA) carrying SCC mec type IV has emerged in hospitals worldwide. The aim of this study was to evaluate phenotypic and molecular characteristics of antimicrobial resistance in MRSA SCC mec IV isolates, presenting different genetic backgrounds, isolated from hospitals in Rio de Janeiro. The antimicrobial resistance of 128 S. aureus type IV isolates from 11 hospitals was characterized by the disk diffusion test and minimum inhibitory concentration (MIC) test. Mutations in par C gene, which encodes ciprofloxacin resistance, and genes associated with macrolide–lincosamide–streptogramin B (MLS b ) resistance were also investigated. MRSA isolates belonging to USA400/ST1 (60 isolates), USA800/ST5 (40), USA1100/ST30 (13), and other 11 (15) lineages were mainly resistant to erythromycin (68%), ciprofloxacin (56%), and clindamycin (50%). The highest antimicrobial resistance rates were found among USA400 isolates ( p  
ISSN:1076-6294
1931-8448
DOI:10.1089/mdr.2015.0255